Financial News

Recent Quotes
My Watchlist
Indicators
Motherlode Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Endo Int'l Plc (NQ: ENDP )

6.695 USD -0.155 (-2.26%)
Streaming Delayed Price Updated: 12:58 PM EST, Mar 4, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Endo Int'l Plc

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Endo International plc Commences Refinancing of its Existing Term Loan
Endo International plc (NASDAQ: ENDP) ("Endo") today announced that it has commenced a refinancing of its existing $3.3 billion senior secured term loan due 2024 with the net proceeds of a new senior... 
From PR Newswire
Endo Reports Fourth-Quarter And Full-Year 2020 Financial Results And Introduces 2021 Financial Guidance
Endo International plc (NASDAQ: ENDP) today reported financial results for the fourth-quarter and full-year ended December 31, 2020 and introduced 2021 financial guidance. 
From PR Newswire
Endo to Participate at J.P. Morgan 2021 Global High Yield & Leveraged Finance Conference
Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan 2021 Global High Yield & Leveraged Finance Conference on Monday, March 1, 2021 at 9:15... 
From PR Newswire
Endo Appoints Jennifer M. Chao to Board of Directors
Endo International plc (NASDAQ: ENDP) today announced that its Board of Directors has appointed Jennifer M. Chao to serve as a director, effective immediately. Ms. Chao has also been appointed to... 
From PR Newswire
Endo to Announce Fourth-Quarter and Full-Year 2020 Financial Results
Endo International plc (NASDAQ: ENDP) will announce its fourth-quarter and full-year 2020 financial results on February 25, 2021 after the market closes and members of its senior management team will... 
From PR Newswire
Endo Announces Licensing Agreement for Paladin Labs Inc. to Commercialize Abaloparatide in Canada
Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited has entered into definitive agreements with Radius Health, Inc. (NASDAQ: RDUS) to register, commercialize... 
From PR Newswire
Radius Health Announces Commercial Agreement with Paladin Labs for Abaloparatide in Canada
From GlobeNewswire News Releases
Endo Aesthetics Launches "Really Cellulite" Campaign
The Unbranded Campaign Is Designed to Clear Up Misinformation and Pique Curiosity About Cellulite 
From PR Newswire
Endo Launches Authorized Generic Version of Amitiza® (lubiprostone) Capsules in the United States
Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping the first authorized generic versions of Mallinckrodt's... 
From PR Newswire
Endo to Participate at J.P. Morgan 39th Annual Healthcare Conference
Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 2:50 p.m. EST. 
From PR Newswire
POINT Biopharma Announces New Board Appointments
From GlobeNewswire News Releases
BioSpecifics Announces Completion of Acquisition by Endo Pharmaceuticals
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed... 
From PR Newswire
Endo Completes Acquisition of BioSpecifics
Endo International plc (NASDAQ: ENDP) announced today that it completed the previously announced acquisition of BioSpecifics Technologies Corp., a commercial-stage biopharmaceutical company, for $88.50... 
From PR Newswire
Endo to Participate In Upcoming Investor Conferences
Endo International plc (NASDAQ: ENDP) announced today that the Company will participate in two investor conferences. 
From PR Newswire
Endo Announces Expiration Of Hart-Scott-Rodino Waiting Period For BioSpecifics Tender Offer
Endo International plc (Nasdaq: ENDP) ("Endo") today announced the expiration of the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"),... 
From PR Newswire
Vizient Updates List of Essential Medications for High-Quality Patient Care; Expands Novaplus Enhanced Supply Program Portfolio
Vizient announces an update to its list of essential medications that hospitals need to provide immediate and high-quality patient care. 
From Business Wire News Releases
Rigrodsky & Long, P.A. Reminds Investors Of Investigation of BioSpecifics Technologies Corp. Buyout
From GlobeNewswire News Releases
BioSpecifics Reports Third Quarter 2020 Financial and Operating Results
- Endo acquisition of BioSpecifics expected to close in 4Q20 
From PR Newswire
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors Of Investigation of BioSpecifics Technologies Corp. Buyout
Rigrodsky & Long, P.A. announces that it is investigating BioSpecifics Technologies Corp. ("BioSpecifics") (NASDAQ GS: BSTC) regarding possible breaches of fiduciary duties and other violations of law... 
From PR Newswire
Endo Reports Third-Quarter 2020 Financial Results And Raises Full Year 2020 Financial Guidance
Endo International plc (NASDAQ: ENDP) today reported financial results for the third-quarter ended September 30, 2020. 
From PR Newswire
Endo Announces Strategic Actions to Further Position the Company for Long-Term Success
Endo International plc (NASDAQ: ENDP) today announced the initiation of several strategic actions to further optimize the Company's operations and increase overall efficiency. These actions are... 
From PR Newswire
Isofol announces licensing agreement for Paladin Labs Inc. to commercialize arfolitixorin in Canada
Isofol Medical AB (publ) ("Isofol"), (Nasdaq First North Premier Growth Market: ISOFOL) is pleased to announce today a definitive license agreement with Endo Ventures Limited, a subsidiary of Endo... 
From PR Newswire
Invitation to a conference call and webcast by Isofol in connection with the entered license agreement for Paladin Labs Inc. to commercialize arfolitixorin in Canada
Isofol Medical AB (publ) ("Isofol"), (Nasdaq First North Premier Growth Market: ISOFOL) has today announced a definitive licensing agreement with Endo Ventures Limited, a subsidiary of Endo... 
From PR Newswire
Endo International plc Commences Tender Offer for All Outstanding Shares of BioSpecifics Technologies Corp.
Endo International plc (Nasdaq: ENDP) ("Endo") today announced that Endo's wholly-owned indirect subsidiary, Beta Acquisition Corp. ("Merger Sub"), has commenced its previously announced tender offer... 
From PR Newswire
Nevakar Announces FDA Approval for Ephedrine Sulfate Injection as Ready-to-Use Vials
From GlobeNewswire News Releases
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of BioSpecifics Technologies Corp.
Rowley Law PLLC is investigating potential securities law violations by BioSpecifics Technologies Corp. (NASDAQ: BSTC) and its board of directors concerning the proposed acquisition of the company by... 
From PR Newswire
BIOSPECIFICS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of BSTC and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of BioSpecifics Technologies Corp. Buyout
From GlobeNewswire News Releases
Endo to Acquire BioSpecifics to Enhance Profitability of XIAFLEX® and Qwo™
Endo International plc (NASDAQ: ENDP) today announced it has agreed to acquire all of the outstanding shares of BioSpecifics Technologies Corp. (NASDAQ: BSTC), a commercial-stage biopharmaceutical... 
From PR Newswire
BioSpecifics to be Acquired by Endo Pharmaceuticals
- All cash transaction at $88.50 per share totaling $658 million in equity value - 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback